Welcome to MadeInn Healthcare

Composition	Cilnidipine 5,10 and 20 mg Tablets.
Indication	Stage I Hypertension
Mechanism of Action	Cilnidipine is a dihydropyridine calcium-channel blocker. It inhibits cellular influx of calcium, thus causing vasodilatation. It has greater selectivity for vascular smooth muscle. It has little or no action at the SA or AV nodes and -ve inotropic activity is rarely seen at therapeutic doses.
Pharmacokinetic's	Rapid absorption. Cmax within 2 h. Highest level in the liver and also distribution in the kidneys, plasma, and other tissues. No tissue showed a particularly high accumulation of the drug following repeated oral administrations. Protein binding 98% The percentage urinary excretion of benidipine following an oral dose is about 36%
Side effects	Dizziness; flushing; headache; hypotension; peripheral oedema; tachycardia; palpitations; GI disturbances; increased micturition frequency; lethargy; eye pain; depression; ischaemic chest pain; cerebral or myocardial ischaemia; transient blindness; rashes; fever; abnormal liver function; gingival hyperplasia; myalgia; tremor; impotence.
Drug drug interaction	-
Precaution	Hypotension, poor cardiac reserve, heart failure. Sudden withdrawal may exacerbate angina. Discontinue in patients who experience ischemic pain following administration. Pregnancy, lactation.
Dosage	Oral Hypertension Adult: 5-10 mg once daily, increase to 20 mg once daily if necessary. Child: 6-16 yr 35 kg: 10 mg once daily; ≥35 kg: 20 mg once daily. Doses may be doubled once if necessary after 2 wk. Elderly: No dosage adjustment needed. Renal impairment: Mild to moderate (CrCl: 20-60 mL/min): Max: 20 mg once daily. Hepatic impairment: Moderate: Initial: 10 mg once daily may increase up to max 20 mg once daily.

Antihypertensive Products

Featured Products